| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Insulet Corporation | Sep 18, 2026 | |
| Buy | INSULET CORPORATION CMN | Sep 11, 2026 | |
| Sell | INSULET CORPORATION CMN | Sep 4, 2026 | |
| Buy | Insulet Corporation | Aug 18, 2026 | |
| Sell | INSULET CORPORATION CMN | Aug 3, 2026 | |
| Sell | INSULET CORPORATION CMN | Jun 16, 2026 | |
| Sell | Insulet Corporation | May 7, 2026 | |
| Sell | Insulet Corporation | Apr 29, 2026 | |
| Buy | INSULET CORPORATION CMN | Nov 15, 2024 | |
| Sell | Insulet Corporation | Apr 4, 2024 |
This page tracks congressional stock trading activity in Insulet Corporation (PODD) in the Healthcare sector. Disclosed Capitol has indexed 26 disclosed congressional trades involving PODD. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of October 2026 — Disclosed Capitol has tracked 26 disclosed congressional trades in Insulet Corporation (PODD) — 16:8 sell-heavy ratio — led by Tina Smith (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Sep 18, 2026 | Gilbert Cisneros | D | Sell | $1,001 - $15,000 |
| Sep 11, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Sep 4, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Aug 18, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Aug 3, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 16, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 7, 2026 | Tina Smith | D | Sell | $100,001 - $250,000 |
| Apr 29, 2026 | Tina Smith | D | Sell | $100,001 - $250,000 |
| Nov 15, 2024 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 4, 2024 | Tina Smith | D | Sell | $50,001 - $100,000 |
Across the 26 disclosed congressional trades in Insulet Corporation (PODD), members of Congress have reported 8 buys and 16 sells. The average 30-day alpha vs. the S&P 500 is 0.14%.
For fiscal year 2025, Insulet Corporation reported revenue of $2.71B and net income of $247.1M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $801.7M, net income $95.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.